MicroRNA expression profiles in oral squamous cell carcinoma

Oncology Reports

Volumn 30, Issue 2, 2013, Pages 579-583

  Soga, Daisuke ^a   Yoshiba, Sayaka ^a   Shiogama, Sunao ^a   Miyazaki, Hiroaki ^a   Kondo, Seiji ^a   Shintani, Satoru ^a  

^a SHOWA UNIVERSITY SCHOOL OF DENTISTRY   (Japan)

Author keywords

Abnormal expression; Exhaustive analysis; microRNA; Oral squamous cell carcinoma

Indexed keywords

MICRORNA; MICRORNA 103; MICRORNA 1291; MICRORNA 133A; MICRORNA 135B; MICRORNA 139 5P; MICRORNA 183; MICRORNA 193A 5P; MICRORNA 200C; MICRORNA 203; MICRORNA 21; MICRORNA 223; MICRORNA 224; MICRORNA 30A 3P; MICRORNA 30E 3P; MICRORNA 31; MICRORNA 376C; MICRORNA 409 3P; MICRORNA 411; MICRORNA 483 5P; MICRORNA 486 5P; MICRORNA 489; MICRORNA 93; UNCLASSIFIED DRUG;

ADULT; AGED; ARTICLE; CANCER DIAGNOSIS; CANCER GROWTH; CANCER PROGNOSIS; CARCINOGENESIS; CLINICAL ARTICLE; CONTROLLED STUDY; DOWN REGULATION; FEMALE; GENE EXPRESSION PROFILING; HUMAN; HUMAN TISSUE; MALE; METASTASIS; MOUTH SQUAMOUS CELL CARCINOMA; PRIORITY JOURNAL; RNA ANALYSIS; UPREGULATION;

CARCINOMA, SQUAMOUS CELL; DISEASE PROGRESSION; FEMALE; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; MALE; MICRORNAS; MOUTH NEOPLASMS; PROGNOSIS; TRANSCRIPTOME;

EID: 84879667449     PISSN: 1021335X     EISSN: 17912431     Source Type: Journal    
DOI: 10.3892/or.2013.2488     Document Type: Article

References (35)

1. Bernier J, Bentzen SM and Vermorken JB: Molecular therapy in head and neck oncology. Nat Rev Clin Oncol 6: 266-277, 2009.
2. Bozec A, Peyrade F, Fischel JL and Milano G: Emerging molecular targeted therapies in the treatment of head and neck cancer. Expert Opin Emerg Drugs 14: 299-310, 2009.
3. Hummel R, Maurer J and Haier J: MicroRNA: biogenesis, function and role in rancer. Curr Genomics 11: 537-561, 2010.
4. Wiemer EA: The role of microRNAs in cancer: no small matter. Eur J Cancer 43: 1529-1544, 2007.
5. Lu J, Getz G, Miska EA, et al: MicroRNA expression profiles classify human cancers. Nature 435: 834-838, 2005. (Pubitemid 40839735)
6. Calin GA and Croce CM: MicroRNA signatures in human cancers. Nat Rev Cancer 6: 857-866, 2006 (Pubitemid 44629897)
7. Wu BH, Xiong XP, Jia J and Zhang WF: MicroRNAs: new actors in the oral cancer scene. Oral Oncol 47: 314-319, 2011.
8. Reis PP, Tomenson M, Cervigne NK, Machado J, Jurisica I and Pintilie M: Programmed cell death 4 loss increases tumor cell invasion and is regulated by miR-21 in oral squamous cell carcinoma. Mol Cancer 10: 238, 2010.
9. Gottardo F, Liu CG, Ferracin M, et al: Micro-RNA profiling in kidney and bladder cancers. Urol Oncol 25: 387-392, 2007. (Pubitemid 47362758)
10. Volinia S, Calin GA, Liu CG, et al: A microRNA expression signature of human solid tumors defines cancer gene targets. Proc Natl Acad Sci USA 103: 2257-2261, 2006. (Pubitemid 43271657)
11. Hammond SM: MicroRNA therapeutics: a new niche for antisense nucleic acids. Trends Mol Med 12: 99-101, 2006.
12. Lagos-Quintana M, Rauhut R, Lendeckel W and Tuschl T: Identification of novel genes coding for small expressed RNAs. Science 294: 853-858, 2001. (Pubitemid 33032103)
13. Bartel DP: MicroRNAs: genomics, biogenesis, mechanism, and function. Cell 116: 281-297, 2004.
14. Ruan K, Fang X and Ouyang G: MicroRNAs: novel regulators in the hallmarks of human cancer. Cancer Lett 285: 116-126, 2009.
15. Farazi TA, Spitzer JI, Morozov P and Tuschl T: miRNAs in human cancer. J Pathol 223: 102-115, 2011.
16. Calin GA, Liu CG, Sevignani C, et al: MicroRNA profiling reveals distinct signatures in B cell chronic lymphocytic leukemias. Proc Natl Acad Sci USA 101: 11755-11760, 2004. (Pubitemid 39095368)
17. Schaefer A, Jung M, Mollenkopf HJ, et al: Diagnostic and prognostic implications of microRNA profiling in prostate carcinoma. Int J Cancer 126: 1166-1176, 2010.
18. Schepeler T, Reinert JT, Ostenfeld MS, et al: Diagnostic and prognostic microRNAs in stage II colon cancer. Clin Chem 54: 1696-1704, 2008.
19. Zhang B, Pan X, Cobb GP and Anderson TA: microRNAs as oncogenes and tumor suppressors. Dev Biol 302: 1-12, 2007. (Pubitemid 46096921)
20. Papagiannakopoulos T, Shapiro A and Kosik KS: MicroRNA-21 targets a network of key tumor-suppressive pathways in glioblastoma cells. Cancer Res 68: 8164-8172, 2008.
21. Rossi L, Bonmassar E and Faraoni I: Modification of miR gene expression pattern in human colon cancer cells following exposure to 5-fluorouracil in vitro. Pharmacol Res 56: 248-253, 2007. (Pubitemid 47321208)
22. Cheng Y, Ji R, Yue J, et al: MicroRNAs are aberrantly expressed in hypertrophic heart: do they play a role in cardiac hypertrophy? Am J Pathol 170: 1831-1840, 2007. (Pubitemid 47339258)
23. Liu X, Cheng Y, Zhang S, Lin Y, Yang J and Zhang C: A necessary role of miR-221 and miR-222 in vascular smooth muscle cell proliferation and neointimal hyperplasia. Circ Res 104: 476-487, 2009.
24. Zhu S, Wu H, Wu F, Nie D, Sheng S and Mo YY: MicroRNA-21 targets tumor suppressor genes in invasion and metastasis. Cell Res 18: 350-359, 2008. (Pubitemid 351333899)
25. Meng F, Henson R, Wehbe-Janek H, Ghoshal K, Jacob ST and Patel T: MicroRNA-21 regulates expression of the PTEN tumor suppressor gene in human hepatocellular cancer. Gastroenterology 133: 647-658, 2007. (Pubitemid 47187346)
26. Löffler D, Brocke-Heidrich K, Pfeifer G, et al: Interleukin-6 dependent survival of multiple myeloma cells involves the Stat3- mediated induction of microRNA-21 through a highly conserved enhancer. Blood 15: 1330-1333, 2007.
27. Schetter AJ, Leung SY, Sohn JJ, Zanetti KA, Bowman ED and Yanaihara N: MicroRNA expression profiles associated with prognosis and therapeutic outcome in colon adenocarcinoma. JAMA 299: 425-436, 2008. (Pubitemid 351185951)
28. Iorio MV, Ferracin M, Liu CG, et al: MicroRNA gene expression deregulation in human breast cancer. Cancer Res 65: 7065-7070, 2005. (Pubitemid 41161233)
29. Nam EJ, Yoon H, Kim SW, Kim H, Kim YT and Kim JH: MicroRNA expression profiles in serous ovarian carcinoma. Clin Cancer Res 14: 2690-2695, 2008.
30. Saini S, Majid S, Yamamura S, et al: Regulatory role of mir-203 in prostate cancer progression and metastasis. Clin Cancer Res 17: 5287-5298, 2011.
31. Wellner U, Schubert J, Burk UC, et al: The EMT-activator ZEB1 promotes tumorigenicity by repressing stemness-inhibiting microRNAs. Nat Cell Biol 11: 1487-1495, 2009.
32. Alder H, Taccioli C, Chen H, et al: Dysregulation of miR-31 and miR-21 induced by zinc deficiency promotes esophageal cancer. Carcinogenesis 33: 1736-1744, 2012.
33. Chang KW, Kao SY, Wu YH, et al: Passenger strand miRNA miR-31(&z.ast;) regulates the phenotypes of oral cancer cells by targeting RhoA. Oral Oncol 49: 27-33, 2013.
34. Wu ZS, Wang CQ, Xiang R, et al: Loss of miR-133a expression associated with poor survival of breast cancer and restoration of miR-133a expression inhibited breast cancer cell growth and invasion. BMC Cancer 12: 51, 2012.
35. Sugimura K, Miyata H, Tanaka K, et al: Let-7 expression is a significant determinant of response to chemotherapy through the regulation of IL-6/STAT3 pathway in esophageal squamous cell carcinoma. Clin Cancer Res 18: 5144-5153, 2012.